Kestra Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Kestra Advisory Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Buy	+1,979	New	+$214K	﹤0.01%	2988
2026 Q1	–	Sell	-1,833	Closed	-$192K	–	4069
2025 Q4	$192K	Buy	+1,833	New	+$184K	﹤0.01%	2924
2025 Q2	–	Sell	-1,575	Closed	-$136K	–	2950
2025 Q1	$136K	Buy	+1,575	New	+$134K	﹤0.01%	2550

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Kestra Advisory Services's PJP Position: Q2 2026 in Review

Kestra Advisory Services opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q2 2026: 1,979 shares worth $234K. The stake represents ﹤0.01% of the portfolio and ranks #2988 among its holdings. This is a return to the name: Kestra Advisory Services previously reported a position in PJP as recently as Q4 2025.

Kestra Advisory Services first reported a position in PJP in Q1 2025 and has held it in 3 quarters since. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Kestra Advisory Services held 1,979 shares of Invesco Pharmaceuticals ETF worth $234K as of Q2 2026.
Invesco Pharmaceuticals ETF was a new Kestra Advisory Services position in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2988 holding.
Kestra Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q1 2025 and has held it in 3 quarters since.
116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.